{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:34:48Z","timestamp":1786628088696,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07403"],"award-info":[{"award-number":["22K07403"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrc.2026.154193","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:37:18Z","timestamp":1782229038000},"page":"154193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Imeglimin enhances GLUT4-mediated glucose uptake and is more effective than metformin in 3T3-L1 adipocytes"],"prefix":"10.1016","volume":"829","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2028-5405","authenticated-orcid":false,"given":"Nobuhiko","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8984-1230","authenticated-orcid":false,"given":"Atsushi P.","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7249-8651","authenticated-orcid":false,"given":"Takayuki","family":"Yoshizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7062-7372","authenticated-orcid":false,"given":"Kazumasa","family":"Ohmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154193_bib1","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","article-title":"Type 2 diabetes","volume":"400","author":"Ahmad","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2026.154193_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","article-title":"Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus","volume":"15","author":"Foretz","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.154193_bib3","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15151","article-title":"Reduced lactic acidosis risk with imeglimin: Comparison with metformin","volume":"10","author":"Theurey","year":"2022","journal-title":"Physiol Rep"},{"key":"10.1016\/j.bbrc.2026.154193_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241651","article-title":"Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action","volume":"16","author":"Hallakou-Bozec","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154193_bib5","first-page":"2","article-title":"Imeglimin - a new oral anti-diabetic that targets the three key defects of type 2 diabetes","author":"Fouqueray","year":"2011","journal-title":"J. Diabetes Metab"},{"key":"10.1016\/j.bbrc.2026.154193_bib6","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41598-023-27689-y","article-title":"Effects of imeglimin on mitochondrial function, AMPK activity, and gene expression in hepatocytes","volume":"13","author":"Hozumi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154193_bib7","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1111\/dom.70449","article-title":"Dual action of imeglimin on insulin secretion and sensitivity in type 2 diabetes","volume":"28","author":"Tajima","year":"2026","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbrc.2026.154193_bib8","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1124\/dmd.120.000154","article-title":"In vitro investigation, pharmacokinetics, and disposition of imeglimin, a novel oral antidiabetic drug, in preclinical species and humans","volume":"48","author":"Clemence","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2026.154193_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155796","article-title":"Imeglimin improves systemic metabolism by targeting brown adipose tissue and gut microbiota in obese model mice","volume":"153","author":"Awazawa","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.bbrc.2026.154193_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122735","article-title":"Imeglimin modulates mitochondria biology and facilitates mitokine secretion in 3T3-L1 adipocytes","volume":"349","author":"Takahashi","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2026.154193_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116906","article-title":"Dreh, a long noncoding RNA repressed by metformin, regulates glucose transport in C2C12 skeletal muscle cells","volume":"236","author":"Takahashi","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2026.154193_bib12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00424-020-02417-x","article-title":"Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease","volume":"472","author":"Chadt","year":"2020","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.bbrc.2026.154193_bib13","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.bcp.2010.08.021","article-title":"Mechanisms of metformin action on glucose transport and metabolism in human adipocytes","volume":"80","author":"Grisouard","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154193_bib14","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2337\/diab.42.8.1159","article-title":"Metformin blocks downregulation of cell surface GLUT4 caused by chronic insulin treatment of rat adipocytes","volume":"42","author":"Kozka","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2026.154193_bib15","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1096\/fj.201800529RR","article-title":"Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity","volume":"33","author":"Polianskyte-Prause","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2026.154193_bib16","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1210\/en.2005-1433","article-title":"Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein kinase-dependent reduction in GLUT4 endocytosis","volume":"147","author":"Yang","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrc.2026.154193_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27083475","article-title":"Canonical and alternative pathways (Insulin and exercise) of GLUT4 synthesis, signaling, intracellular clustering, and recruitment to the plasma membrane","volume":"27","author":"Ramos-Jimenez","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154193_bib18","doi-asserted-by":"crossref","first-page":"44121","DOI":"10.1074\/jbc.M112.361386","article-title":"Metformin regulates glucose transporter 4 (GLUT4) translocation through AMP-activated protein kinase (AMPK)-mediated Cbl\/CAP signaling in 3T3-L1 preadipocyte cells","volume":"287","author":"Lee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154193_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/BJ20061489","article-title":"Exploring the specificity of the PI3K family inhibitor LY294002","volume":"404","author":"Gharbi","year":"2007","journal-title":"Biochem. J."},{"issue":"Pt 3","key":"10.1016\/j.bbrc.2026.154193_bib20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1042\/bj3330471","article-title":"Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling","volume":"333","author":"Shepherd","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2026.154193_bib21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diab.37.6.667","article-title":"Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM","volume":"37","author":"DeFronzo","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2026.154193_bib22","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1172\/JCI115068","article-title":"Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity","volume":"87","author":"Garvey","year":"1991","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.154193_bib23","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/35055575","article-title":"Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver","volume":"409","author":"Abel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154193_bib24","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2337\/db16-0221","article-title":"GLUT4 Expression in Adipocytes Regulates De Novo Lipogenesis and Levels of a Novel Class of Lipids With Antidiabetic and Anti-inflammatory Effects","volume":"65","author":"Moraes-Vieira","year":"2016","journal-title":"Diabetes"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26009575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26009575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:54:14Z","timestamp":1786625654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26009575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":24,"alternative-id":["S0006291X26009575"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154193","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imeglimin enhances GLUT4-mediated glucose uptake and is more effective than metformin in 3T3-L1 adipocytes","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154193"}}